Manufacture

We look at some of the latest studies and research announcements focused on improving gene therapy.

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Overcoming the limitations of the triple plasmid transient transfection method for AAV manufacturing.

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.

The 2025 Power List will be available soon!

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

Michiel van den Berg sheds light on the challenges and opportunities facing the industry as it adapts to new materials and regulatory requirements